ArticlePharmaceuticals (Basel, Switzerland)2022

Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking.

Laura González-Cofrade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.